Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Pancreatic Fistula Prevention
NCT02920567Unknown
- Sponsor
- St Vincent's Hospital
- Start
- Jan 2014
- Primary completion
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised trial of Octreotide long-acting injection in Periampullary tumors (2 arms), sponsored by St Vincent's Hospital. Primary endpoint: Amount of pancreatic secretion at 1 day. Status: unknown.
02
Drugs
Octreotide long-acting injection
03
Conditions
Periampullary tumors
Beyond the preview
Go deeper on NCT02920567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02920567.